bouncer
← Back

New York Post · 2.8K views · 28 likes Short

Analysis Summary

40% Low Influence
mildmoderatesevere

“Be aware that the video uses extreme personal anecdotes (e.g., a woman not wanting her husband to kiss her) to create an emotional hook for a broader marketing campaign for the outlet's health series.”

Transparency Mostly Transparent
Primary technique

Performed authenticity

The deliberate construction of "realness" — confessional tone, casual filming, strategic vulnerability — designed to lower your guard. When someone appears unpolished and honest, you evaluate their claims less critically. The spontaneity is rehearsed.

Goffman's dramaturgy (1959); Audrezet et al. (2020) on performed authenticity

Human Detected
95%

Signals

The video features a named human reporter discussing her own original reporting and interviews, exhibiting natural speech patterns and professional journalistic standards. There are no indicators of synthetic narration or automated content farming.

Personal Identification The narrator identifies herself as McKenzie Beard, a specific wellness reporter for the New York Post, and references her own reporting and interviews.
Speech Patterns The transcript contains natural phrasing and professional journalistic cadence consistent with a news reporter rather than a synthetic script.
Source Credibility The content is published by a verified legacy media organization (New York Post) featuring their own staff reporter.

Worth Noting

Positive elements

  • The video provides a concise biological explanation of how GLP-1 drugs interact with the brain's reward centers beyond just appetite suppression.

Be Aware

Cautionary elements

  • The use of sensationalized personal anecdotes to frame a medical side effect as a dramatic 'loss' to drive clicks to a larger series.

Influence Dimensions

How are these scored?
About this analysis

Knowing about these techniques makes them visible, not powerless. The ones that work best on you are the ones that match beliefs you already hold.

This analysis is a tool for your own thinking — what you do with it is up to you.

Analyzed March 23, 2026 at 20:38 UTC Model google/gemini-3-flash-preview-20251217
Transcript

Weight loss isn't the only thing GLP-1 users are losing. I'm McKenzie Beard, a wellness reporter with the New York Post, and I spoke to several women who told me that after starting medications like Ozek and Munjaro, their sex drives tanked. Before starting the medications, they described having a high libido and getting intimate several times a week. But after starting the shots, they felt almost no desire at all, with one woman not even wanting her husband to kiss her. Doctors told me this can be a common experience. GLP-1s work by mimicking hormones released in the gut after eating, helping regulate appetite and blood sugar. But those hormones also interact with the brain, including areas tied to reward and pleasure. That can mean fewer signals pushing you to seek out things like food or sex. Add in rapid weight loss, and the body can shift into a sort of conservation mode where libido takes a backseat as everything recalibrates. But it's not universal. In fact, some GLP-1 users report experiencing an increase in libido due to things like weight loss, better health, and more confidence. Women dealing with a drop in libido told me that they've tried supplements and peptide therapies to help, though one woman admitted she'd rather be thin than sexually active. Another said she got her groove back after her body adjusted to the medication. Want to learn more? Check out the full story in our GLP-1 series, The Thin Line, at the link in our bio.

Video description

Christine Smith-Reed had tried it all: a dietitian, grueling workouts, even weight-loss surgery in Mexico. Yet the pounds kept creeping up, and her body was becoming insulin resistant. NY Post wellness reporter Mckenzie Beard shares this story. So at 50, the salon owner from Columbia City, Oregon, turned to tirzepatide, the active ingredient in GLP-1 drugs like Mounjaro and Zepbound, hoping to rein in her blood sugar and finally stabilize the scale. Ultimately, she got the body she wanted — but weight wasn’t the only thing she lost. Read more at https://nypost.com/2026/02/26/health/we-lost-weight-on-glp-1-drugs-and-then-lost-our-sex-drives/ #glp1 #weight The New York Post is your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more. Check out our three new podcasts: NYNext (week): https://www.youtube.com/@nynext1 Pod Force One with MIranda Devine (weekly): https://www.youtube.com/@PodForce1 NY POSTcast (daily): https://www.youtube.com/@NYPOSTcast Get The Post’s latest headlines everyday with our Morning Report newsletter: https://tinyurl.com/NYPOSTSIGNUP Catch the latest news at http://www.nypost.com. Follow The New York Post on: Twitter - https://twitter.com/nypost Facebook - https://www.facebook.com/NYPost

© 2026 GrayBeam Technology Privacy v0.1.0 · ac93850 · 2026-04-03 22:43 UTC